RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 39 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,660,352 | +19.6% | 218,037 | +3.0% | 0.00% | – |
| Q2 2023 | $1,388,214 | +1315.5% | 211,618 | +1190.4% | 0.00% | – |
| Q1 2023 | $98,072 | +28.3% | 16,400 | -50.0% | 0.00% | – |
| Q4 2022 | $76,424 | +39.0% | 32,800 | +100.0% | 0.00% | – |
| Q3 2022 | $55,000 | +27.9% | 16,400 | 0.0% | 0.00% | – |
| Q2 2022 | $43,000 | -83.6% | 16,400 | -81.6% | 0.00% | – |
| Q1 2022 | $262,000 | -65.2% | 89,253 | +1.4% | 0.00% | – |
| Q4 2021 | $753,000 | +17.5% | 88,063 | +2.4% | 0.00% | – |
| Q3 2021 | $641,000 | +12.9% | 86,014 | +41.2% | 0.00% | – |
| Q2 2021 | $568,000 | – | 60,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |